Biologics Safety Testing Market by Product, Test, Application - Global Forecast to 2022

  • ID: 4335965
  • Report
  • Region: Global
  • 142 Pages
  • Markets and Markets
1 of 6
Biologics Safety Testing Market was Valued at USD 2.75 Billion in 2017 and Expected to Grow at a CAGR of 12.2% to a USD 4.90 Billion Market by 2022

FEATURED COMPANIES

  • Avance Biosciences Inc.
  • Cytovance Biologics
  • Genscript
  • Lonza Group Ltd
  • Promocell GmbH
  • Source Bioscience
  • MORE

"Biologics Safety Testing Market by Product (Instruments, Services, Kits & Reagents), Test (Endotoxin, Sterility Test, Cell Line Authentication, Bioburden), Application (Vaccine Development, Blood Products, Stem Cell Research) - Global Forecast to 2022"

The biologics safety testing market was valued at USD 2.75 billion in 2017 and expected to grow at a CAGR of 12.2% to a USD 4.90 billion market by 2022. Growth in pharmaceutical and biotechnology industry driven by government support, the positive trend of R&D investment in the life science industry, and an increase in the number of new drug launches are factors driving the growth of this market. On the other hand, the time-consuming approval process for new drugs is considered a restraint for the market.

"Kits & reagents segment is expected to register the highest CAGR during the forecast period"

The biologics safety testing market is classified on the basis of product & service into kits & reagents, services, and instruments. The kits & reagents segment is expected to register highest growth rate during the forecast period. This growth can be attributed to the reoccurring purchase of kits & reagents, which is required for running tests.

"Endotoxin tests segment is accounted for largest share in the market"

The biologics safety testing market is classified by test type into endotoxin tests, sterility tests, cell line authentification and characterization tests, residual host contamination detection tests, adventitious agent detection tests, bioburden tests, and other tests. The endotoxin tests segment is expected to register the highest growth rate during the forecast period. This growth can be attributed to the increase in the number of drug launches.

"Increase initiative for immunization, increase company investment in vaccines development drives growth of the vaccines and therapeutics development segment"

By application, the biologics safety testing market is segmented into vaccine and therapeutics development; blood and blood-related products testing; cellular and gene therapy; tissue and tissue-related products testing; and stem cell research. The vaccine and therapeutics development segment are expected to register highest CAGR during the forecast period. The growth in this segment primarily attributed to initiatives for immunization and increased company investment in the development of vaccines.

"North America is account for the largest regional segment in the market"

Geographically, the biologics safety testing market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share of the market in 2017 and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region, a strong trend in R&D in life science industry and an increase in drug approvals.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 43%, Tier 2 - 14% and Tier 3 - 43%
  • By Designation - C level - 14%, Director level - 43%, Others - 43%
  • By Region - North America - 29%, Europe - 14%, APAC - 43%, RoW - 14%

Key players operating in the biologics safety testing market include Lonza Group LTD. (Switzerland), Charles River Laboratories (U.S.), Merck KGaA (Germany), SGS SA (Switzerland), WuXi Apptec (China), Thermo Fisher Scientific Inc. (U.S.), Sartorius AG (Germany), Cytovance Biologics, Inc. (U.S.), Pace Analytical Services Inc. (U.S.), and Toxikon Corporation (U.S.).

Study Coverage:

The report analyses the biologics safety testing market by product & service, test type, applications, and regions. Apart from comprehensive geographic and product & service analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with developments, and strategies adopted by key players to maintain and increase their shares in the market. The market research data, market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.

Benefits of Buying this Report:

This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:

  • Market Penetration: The report analyzes the biologics safety testing market by product & service, test type and application
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the biologics safety testing market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various biologics safety testing product & service across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the biologics safety testing market.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Avance Biosciences Inc.
  • Cytovance Biologics
  • Genscript
  • Lonza Group Ltd
  • Promocell GmbH
  • Source Bioscience
  • MORE

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology
    2.1 Research Approach
    2.2 Research Data
           2.2.1 Secondary Sources
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Sources
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Breakdown of Primary Interviews
    2.3 Market Size Estimation
    2.4 Market Breakdown and Data Triangulation
    2.5 Research Assumptions

3 Executive Summary

4 Biologics Safety Testing Market: Premium Insights
    4.1 Biologics Safety Testing: Market Overview
    4.2 Geographic Analysis: By Product & Service (2017)
    4.3 Geographic Snapshot of the Global Market
    4.4 Global Market, By Application 2017 vs 2022

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growth in Pharmaceutical and Biotechnology Industries Driven By Government Support
                    5.2.1.2 Positive Trend of R&D Investments in Life Science
                    5.2.1.3 Increase in Number of Drug Launches
                    5.2.1.4 High Incidence and Large Economic Burden of Chronic Diseases
           5.2.2 Opportunities
                    5.2.2.1 Emerging Markets
                    5.2.2.2 Increasing Pharmaceutical Outsourcing
           5.2.3 Challenge
                    5.2.3.1 Dearth of Skilled Professionals

6 Biologics Safety Testing Market, By Product and Service
    6.1 Introduction
    6.2 Kits & Reagents
    6.3 Services
    6.4 Instruments

7 Biologics Safety Testing Market, By Test Type
    7.1 Introduction
    7.2 Endotoxin Tests
    7.3 Sterility Tests
    7.4 Cell Line Authentication and Characterization Tests
    7.5 Bioburden Tests
    7.6 Residual Host Contaminant Detection Tests
    7.7 Adventitious Agent Detection Tests
    7.8 Other Tests

8 Biologics Safety Testing Market, By Application
    8.1 Introduction
    8.2 Vaccine & Therapeutics Development
    8.3 Blood and Blood-Related Products Testing
    8.4 Cellular and Gene Therapy
    8.5 Tissue and Tissue-Related Products Testing
    8.6 Stem Cell Research

9 Biologics Safety Testing Market, By Region
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 U.K.
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe (RoE)
    9.4 Asia
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia
    9.5 Rest of the World
           9.5.1 South America, Central America, and the Caribbean
           9.5.2 Pacific and Oceania
           9.5.3 Africa

10 Competitive Landscape
     10.1 Overview
             10.1.1 Visionary Leaders
             10.1.2 Innovators
             10.1.3 Dynamic Differentiators
             10.1.4 Emerging Companies
     10.2 Competitive Benchmarking
             10.2.1 Strength of Product Portfolio
             10.2.2 Business Strategy Excellence
     10.3 Market Share Analysis

*Top 25 Companies Analyzed for This Studies are - Sartorius AG (Germany), SGS SA (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), Lonza Group Ltd (Switzerland), Charles River Laboratories, Inc. (U.S.), Merck KGaA (Germany), Eurofins Scientific  Se (Luxembourg), Source Bioscience (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Cytovance Biologics (U.S.), Toxikon Corporation (U.S.), Avance Biosciences Inc. (U.S.), Pace Analytical Services LLC. (U.S.), Wuxi Apptec (China), Biomérieux Sa (France), Sterigenics International LLC (U.S.), Clean Cells (France), Bsl Bioservice Scientific Laboratories Munich GmbH (Germany), North American Science Associates Inc. (U.S.), Promocell GmbH (Germany), Genscript (China), Gibraltar Laboratories (U.S.), Invivogen (U.S.), Neopharm Labs Inc. (Canada), Virusure GmbH (Austria)

11 Company Profiles
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
     11.1 Charles River Laboratories International, Inc.
     11.2 Merck KGaA
     11.3 Lonza Group Ltd.
     11.4 SGS S.A.
     11.5 Thermo Fisher Scientific Inc.
     11.6 Wuxi Apptec
     11.7 Sartorius AG
     11.8 Cytovance Biologics, Inc.
     11.9 Pace Analytical Services Inc.
     11.10 Toxikon Corporation
     11.11 Eurofins Scientific Se
     11.12 Avance Biosciences Inc.
     11.13 Source Bioscience

*Details on View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables

Table 1 Biologics Safety Testing Market Summary
Table 2 Market, By Product and Service, 2015-2022 (USD Million)
Table 3 Biologics Safety Testing Kits and Reagents Market, By Region, 2015-2022 (USD Million)
Table 4 Biologics Safety Testing Services Market, By Region, 2015-2022 (USD Million)
Table 5 Biologics Safety Testing Instruments Market, By Region, 2015-2022 (USD Million)
Table 6 Market Size, By Test Type, 2015-2022 (USD Million)
Table 7 Endotoxin Tests Market, By Region, 2015-2022 (USD Million)
Table 8 Sterility Tests Market, By Region, 2015-2022 (USD Million)
Table 9 Cell Line Authentication and Characterization Tests Market, By Region, 2015-2022 (USD Million)
Table 10 Bioburden Tests Market, By Region, 2015-2022 (USD Million)
Table 11 Residual Host Contaminant Detection Tests Market, By Region, 2015-2022 (USD Million)
Table 12 Adventitious Agent Detection Tests Market, By Region, 2015-2022 (USD Million)
Table 13 Other Biologics Safety Tests Market, By Region, 2015-2022 (USD Million)
Table 14 Biologics Safety Testing Market, By Application, 2015-2022 (USD Million)
Table 15 Market for Vaccine and Therapeutics Development, By Region, 2015-2022 (USD Million)
Table 16 Market for Blood and Blood-Related Products Testing, By Region, 2015-2022 (USD Million)
Table 17 Market for Cellular and Gene Therapy Products, By Region, 2015-2022 (USD Million)
Table 18 Market for Tissue and Tissue-Related Products Testing, By Region, 2015-2022 (USD Million)
Table 19 Market for Stem Cell Research, By Region, 2015-2022 (USD Million)
Table 20 Market, By Region, 2015-2022 (USD Million)
Table 21 North America: Biologics Safety Testing Market, By Country, 2015-2022 (USD Million)
Table 22 North America: Market, By Application, 2015-2022 (USD Million)
Table 23 North America: Market, By Product & Service, 2015-2022 (USD Million)
Table 24 North America: Market, By Test Type, 2015-2022 (USD Million)
Table 25 U.S.: Market, By Application, 2015-2022 (USD Million)
Table 26 U.S.: Market, By Product & Service, 2015-2022 (USD Million)
Table 27 Canada: Biologics Safety Testing Market, By Application, 2015-2022 (USD Million)
Table 28 Canada: Market, By Product & Service, 2015-2022 (USD Million)
Table 29 Europe: Market, By Country, 2015-2022 (USD Million)
Table 30 Europe: Market, By Application, 2015-2022 (USD Million)
Table 31 Europe: Market, By Product & Service, 2015-2022 (USD Million)
Table 32 Europe: Market, By Test Type, 2015-2022 (USD Million)
Table 33 Germany: Biologics Safety Testing Market, By Application, 2015-2022 (USD Million)
Table 34 Germany: Market, By Product & Service, 2015-2022 (USD Million)
Table 35 U.K.: Market, By Application, 2015-2022 (USD Million)
Table 36 U.K.: Market, By Product & Service, 2015-2022 (USD Million)
Table 37 France: Biologics Safety Testing Market, By Application, 2015-2022 (USD Million)
Table 38 France: Market, By Product & Service, 2015-2022 (USD Million)
Table 39 Italy: Market, By Application, 2015-2022 (USD Million)
Table 40 Italy: Market, By Product & Service, 2015-2022 (USD Million)
Table 41 Spain: Market, By Application, 2015-2022 (USD Million)
Table 42 Spain: Market, By Product & Service, 2015-2022 (USD Million)
Table 43 RoE: Biologics Safety Testing Market, By Application, 2015-2022 (USD Million)
Table 44 RoE: Market, By Product & Service, 2015-2022 (USD Million)
Table 45 Asia: Market, By Country, 2015-2022 (USD Million)
Table 46 Asia: Market, By Application, 2015-2022 (USD Million)
Table 47 Asia: Market, By Product & Service, 2015-2022 (USD Million)
Table 48 Asia: Market, By Test Type, 2015-2022 (USD Million)
Table 49 China: Biologics Safety Testing Market, By Application, 2015-2022 (USD Million)
Table 50 China: Market, By Product & Service, 2015-2022 (USD Million)
Table 51 Japan: Market, By Application, 2015-2022 (USD Million)
Table 52 Japan: Market, By Product & Service, 2015-2022 (USD Million)
Table 53 India: Biologics Safety Testing Market, By Application, 2015-2022 (USD Million)
Table 54 India: Market, By Product & Service, 2015-2022 (USD Million)
Table 55 Rest of Asia: Market, By Application, 2015-2022 (USD Million)
Table 56 Rest of Asia: Market, By Product & Service, 2015-2022 (USD Million)
Table 57 RoW: Biologics Safety Testing Market, By Region, 2015-2022 (USD Million)
Table 58 RoW: Market, By Application, 2015-2022 (USD Million)
Table 59 RoW: Market, By Product & Service, 2015-2022 (USD Million)
Table 60 RoW: Market, By Test Type, 2015-2022 (USD Million)
Table 61 South America, Central America, & the Caribbean: Market, By Application, 2015-2022 (USD Million)
Table 62 South America, Central America, & the Caribbean: Market, By Product & Service, 2015-2022 (USD Million)
Table 63 Pacific and Oceania: Biologics Safety Testing Market, By Application, 2015-2022 (USD Million)
Table 64 Pacific and Oceania: Market, By Product & Service, 2015-2022 (USD Million)
Table 65 Africa: Market, By Application, 2015-2022 (USD Million)
Table 66 Africa: Market, By Product & Service, 2015-2022 (USD Million)

List of Figures

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Biologics Safety Testing Market Size, By Product & Service, 2017 vs 2022 (USD Million)
Figure 7 Global Market Size, By Application, 2017 vs 2022 (USD Million)
Figure 8 Global Market Size, By Test Type, 2017 vs 2022 (USD Million)
Figure 9 Global Market Size, By Region, 2017 vs 2022 (USD Million)
Figure 10 Global Market to Register A High, Double-Digit Growth Rate in the Forecast Period
Figure 11 Kits & Reagents Segment to Dominate the Biologics Safety Testing Market in 2017
Figure 12 Asia to Register the Highest CAGR During the Forecast Period
Figure 13 Vaccine and Therapeutics Development Will Continue to Dominate the Global Market 2022
Figure 14 Global Market: Drivers, Restraints, Opportunities, & Challenges
Figure 15 Kits & Reagents Segment to Dominate the Market During the Forecast Period
Figure 16 Endotoxin Tests Segment to Dominate the Global Market During the Forecast Period
Figure 17 Vaccine & Therapeutics Development to Dominate the Biologics Safety Testing Market During the Forecast Period
Figure 18 North America to Dominate the Global Market in 2017
Figure 19 Asia to Register the Highest CAGR During the Forecast Period (2017-2022)
Figure 20 U.S. to Witness the Highest Growth Rate in the North American Global Market During the Forecast Period (2017-2022)
Figure 21 North America: Market Snapshot
Figure 22 Germany to Witness the Highest Growth Rate in the European Market During the Forecast Period (2017-2022)
Figure 23 Asia: Market, By Country (2017)
Figure 24 Asia: Market Snapshot
Figure 25 Rest of the World: Market, By Region (2017)
Figure 26 Market (Global) Competitive Leadership Mapping, 2017
Figure 27 Market: Market Share (2016)
Figure 28 Charles River Laboratories International, Inc.: Company Snapshot (2016)
Figure 29 Merck KGaA: Company Snapshot (2016)
Figure 30 Lonza Group Ltd.: Company Snapshot (2016)
Figure 31 SGS S.A.: Company Snapshot (2016)
Figure 32 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 33 Sartorius AG: Company Snapshot (2016)
Figure 34 Eurofins Scientific Se: Company Snapshot (2016)
Figure 35 Source Bioscience: Company Snapshot (2015)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Avance Biosciences Inc.
  • Biomérieux Sa
  • Bsl Bioservice Scientific Laboratories Munich GmbH
  • Charles River Laboratories International, Inc.
  • Clean Cells
  • Cytovance Biologics
  • Eurofins Scientific Se
  • F. Hoffmann-La Roche Ltd.
  • Genscript
  • Gibraltar Laboratories
  • Invivogen
  • Lonza Group Ltd
  • Merck KGaA
  • Neopharm Labs Inc.
  • North American Science Associates Inc.
  • Pace Analytical Services Inc.
  • Promocell GmbH
  • SGS S.A.
  • Sartorius AG
  • Source Bioscience
  • Sterigenics International LLC
  • Thermo Fisher Scientific Inc.
  • Toxikon Corporation
  • Virusure GmbH
  • Wuxi Apptec
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll